
Company valuation, historical trends, and peer comparisons.
According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.66B. This represents a change of 27.53% compared to the average of 1.30B of the last 4 quarters.
The mean historical Enterprise Value of Pacira BioSciences, Inc. over the last ten years is 2.07B. The current 1.66B Enterprise Value has changed -19.88% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Enterprise Value was at its highest in in the March 2022 quarter at 4.20B. The Enterprise Value was at its lowest in in the September 2024 quarter at 1.09B.
Average
2.07B
Median
2.02B
Minimum
1.23B
Maximum
3.21B
Discovering the peaks and valleys of Pacira BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.02%
Maximum Annual Enterprise Value = 3.21B
Minimum Annual Increase = -53.70%
Minimum Annual Enterprise Value = 1.23B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.45B | 17.50% |
| 2024 | 1.23B | -38.09% |
| 2023 | 1.99B | -17.57% |
| 2022 | 2.42B | -24.63% |
| 2021 | 3.21B | 7.08% |
| 2020 | 2.99B | 39.01% |
| 2019 | 2.15B | 12.29% |
| 2018 | 1.92B | -5.94% |
| 2017 | 2.04B | 60.02% |
| 2016 | 1.27B | -53.70% |
The current Enterprise Value of Pacira BioSciences, Inc. (PCRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.56B
5-year avg
2.06B
10-year avg
2.07B
Pacira BioSciences, Inc.’s Enterprise Value is less than Latigo Biotherapeutics Inc. (0), greater than Collegium Pharmaceutical, Inc. (1.50B), greater than Scilex Holding Company (108.00M), less than Supernus Pharmaceuticals, Inc. (2.30B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 0 | $823.50M | |
| 1.50B | $773.02M | |
| 108.00M | $13.01M | |
| 2.30B | $2.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pacira BioSciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Pacira BioSciences, Inc. (PCRX)?
What is the 3-year average Enterprise Value for Pacira BioSciences, Inc. (PCRX)?
What is the 5-year average Enterprise Value for Pacira BioSciences, Inc. (PCRX)?
How does the current Enterprise Value for Pacira BioSciences, Inc. (PCRX) compare to its historical average?